Center for Cancer Nanotechnology Excellence
for Translational Diagnostics (CCNE-TD)
The USC/Norris Comprehensive Cancer Center, is a national resource for cancer research, treatment, prevention and education. Nearly 200 basic scientists, physicians from the faculty of Keck School of Medicine of USC and several USC professional schools/departments and the College of Letters, Arts and Sciences who are members of the USC/Norris Cancer Center investigate the complex origins and progression of cancer, develop prevention strategies and search for cures. The National Cancer Institute (NCI) has designated the USC/Norris Cancer Center as one of the nation's 40 comprehensive cancer centers, a select group of institutions providing leadership in cancer treatment, research, prevention and education. USC/Norris has held this designation since 1973, when it was named as one of the first eight comprehensive cancer centers. Research at USC/Norris is organized into five thematic programs (molecular genetics, epigenetics and regulation, tumor microenvironment, cancer epidemiology and cancer control research), five translational research programs (genitourinary cancers, gastrointestinal cancers, women’s cancers, and hematologic and viral-associated malignancies) and a "bridge" program in developmental therapeutics.